Rachel B. Danis

ORCID: 0000-0003-4126-5323 · 2 papers in corpus
editorial 2023
F&S reports ·doi:10.1016/j.xfre.2023.04.002
article 2021
F&S reports ·doi:10.1016/j.xfre.2021.05.009

OBJECTIVE: To investigate the efficacy of elagolix when administered at different time points in a menstrual cycle. DESIGN: Clinical case series. SETTING: Academic reproductive endocrinology center. PATIENTS: Ovulatory women not desiring pr…